Fluoroethoxy-1,4-diphenethylpiperidine and piperazine derivatives: Potent and selective inhibitors of [3H]dopamine uptake at the vesicular monoamine transporter-2

https://doi.org/10.1016/j.bmcl.2017.10.039Get rights and content

Abstract

A small library of fluoroethoxy-1,4-diphenethyl piperidine and fluoroethoxy-1,4-diphenethyl piperazine derivatives were designed, synthesized and evaluated for their ability to inhibit [3H]dopamine (DA) uptake at the vesicular monoamine transporter-2 (VMAT2) and dopamine transporter (DAT), [3H]serotonin (5-HT) uptake at the serotonin transporter (SERT), and [3H]dofetilide binding at the human-ether-a-go-go-related gene (hERG) channel. The majority of the compounds exhibited potent inhibition of [3H]DA uptake at VMAT2, Ki changes in the nanomolar range (Ki = 0.014–0.073 µM). Compound 15d exhibited the highest affinity (Ki = 0.014 µM) at VMAT2, and had 160-, 5-, and 60-fold greater selectivity for VMAT2 vs. DAT, SERT and hERG, respectively. Compound 15b exhibited the greatest selectivity (>60-fold) for VMAT2 relative to all the other targets evaluated, and 15b had high affinity for VMAT2 (Ki = 0.073 µM). Compound 15b was considered the lead compound from this analog series due to its high affinity and selectivity for VMAT2.

Section snippets

Acknowledgements

This research was supported by DA013519, TR000117, TR001998 and GM109005 NIH grants, and an Arkansas Research Alliance (ARA) Scholar award. The University of Kentucky holds patents on the novel compounds described herein. A potential royalty stream to LPD and PAC may occur consistent with University of Kentucky policy.

References (26)

  • M. Iyo et al.

    Prog Neuropsychopharmacol Biol Psychiatry

    (1997)
  • V. Shetty et al.

    J Am Dent Assoc

    (2010)
  • L.P. Dwoskin et al.

    Biochem Pharmacol

    (2002)
  • J.A. Court et al.

    Brain Res

    (1994)
  • D.K. Miller et al.

    Pharmacol Biochem Behav

    (2003)
  • N.M. Neugebauer et al.

    Eur J Pharmacol

    (2007)
  • J.R. Nickell et al.

    Bioorg Med Chem Lett

    (2016)
  • J.R. Nickell et al.

    Bioorg Med Chem Lett

    (2016)
  • S.R. Joolakanti et al.

    Bioorg Med Chem Lett

    (2016)
  • J.R. Nickell et al.

    Behav Pharmacol

    (2017)
  • United Nations Office on Drugs and Crimes (UNODC). 2004 World Drug Report....
  • T.E. Nordahl et al.

    J Neuropsychiatry Clin Neurosci

    (2003)
  • A.M. Barr et al.

    J Psychiatry Neurosci

    (2006)
  • Cited by (2)

    View full text